Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma
International Journal of Molecular Sciences · 08.07.2026 · 27 (14) · 6103
DOI: 10.3390/ijms27146103 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 08.07.2026. Verfasst von Panagiotis Malamos und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece. Hauptthemen laut MEDLINE: Multiple Myeloma, DNA Damage, Leukocytes, Mononuclear. Die Arbeit nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union.
Abstract (Originalsprache)
Alterations in the redox status and the DNA damage response (DDR) parameters are early, mechanistically interconnected drivers of carcinogenesis. Herein, we investigated whether such alterations, arising during the progression of Multiple Myeloma (MM), are systemically reflected in peripheral blood mononuclear cells (PBMCs). Redox status, expressed as the GSH/GSSG ratio, and DDR-related parameters, including baseline DNA damage, efficiency of key DNA repair pathways, namely nucleotide excision repair (NER) and double-strand break repair (DSB/R), as well as apoptotic sensitivity, were evaluated in PBMCs from 17 patients with Monoclonal Gammopathy of Undetermined Significance (MGUS), 20 with smoldering MM (SMM), and 19 with MM. PBMCs from 20 healthy controls (HCs) were analyzed in parallel. Baseline DNA damage levels and DNA repair capacities across all examined pathways increased progressively in the following order: HC < MGUS < SMM < MM (p < 0.001). This progression was accompanied by a gradual increase in chromatin relaxation. Conversely, the GSH/GSSG ratio and apoptotic sensitivity declined during disease progression (p < 0.001). Collectively, malignant transformation in MM is associated with progressive dysregulation of DDR pathways and redox status in PBMCs. The identification of these molecular perturbations in an easily accessible tissue, such as peripheral blood, underscores their potential utility for early detection and prognostic assessment of MM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Chemical Biology, National Hellenic Research Foundation, 116 35 Athens, Greece.
- Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, 176 76 Athens, Greece.
- Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, 115 28 Athens, Greece.
- Proteomics Core Facility, School of Science, National and Kapodistrian University of Athens, 157 71 Athens, Greece.
ORCID-Profile: Panagiotis Malamos, Konstantinos Koutoulogenis, Julie Courraud, Christine-Ivy Liacos, Eirini Solia, Evangelos Terpos, Meletios A Dimopoulos, Efstathios Kastritis, Vassilis L Souliotis
Förderung
- European Union
Zitieren
APA
Malamos, P., Deligianni, E., Koutoulogenis, K., Courraud, J., Liacos, C. I., Solia, E., Terpos, E., Dimopoulos, M. A., Kastritis, E., & Souliotis, V. L. (2026). Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma. International Journal of Molecular Sciences, 27(14), 6103. https://doi.org/10.3390/ijms27146103
Vancouver
Malamos P, Deligianni E, Koutoulogenis K, Courraud J, Liacos CI, Solia E, et al. Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma. International Journal of Molecular Sciences. 2026;27(14):6103. doi:10.3390/ijms27146103
BibTeX
@article{Malamos2026,
author = {Malamos, Panagiotis and Deligianni, Elisavet and Koutoulogenis, Konstantinos and Courraud, Julie and Liacos, Christine-Ivy and Solia, Eirini and Terpos, Evangelos and Dimopoulos, Meletios A and Kastritis, Efstathios and Souliotis, Vassilis L},
title = {Signals in Peripheral Blood: Tracking Redox Status and DNA Damage Response During the Progression of Multiple Myeloma},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {14},
pages = {6103},
doi = {10.3390/ijms27146103}
}
EUVIMED